BBC Science Focus Magazine: An End To Aging? January 29, 2022 Juvenescence co-founder Jim Mellon gives his perspective on how advances in extending human life will impact the world economy and healthcare systems.
Forbes: AI And Optimism: Jim Mellon Wants Us All To Live Longer January 27, 2022 Juvenescence co-founder Jim Mellon doubles down on how science will change lifespan and the business opportunities in longevity.
Longevity Technology: Longevity Companies to Watch in 2021 January 04, 2021 Juvenescence and its partners – the Buck Institute for Research on Aging, Insilico Medicine, and LyGenesis – have been identified as leaders who are driving important scientific advances in the...
Allure: ‘Our Average Life Expectancy Could Increase to 115 Years Very Soon’ August 18, 2020 Dr. Greg Bailey, CEO of Juvenescence shares his insights on the future of aging with Allure. He discusses increasing lifespan in humans, a burst of investment in the longevity space...
Longevity Technology: ‘Greg Bailey on Democratizing Healthcare, Paradigm Shifts & Disruptive Technologies’ September 26, 2019 Dr. Greg Bailey, CEO of Juvenescence gives an interview to Longevity Technology to discuss his thoughts on the longevity field and future plans for Juvenescence.
Forbes: ‘Extraordinary breakthroughs in Anti-Aging Research ‘Will Happen Faster Than People Think’ August 26, 2019 Scientific breakthroughs in anti-aging research have been occurring at an exponential pace, as highlighted in Forbes featuring Juvenescence CEO, Dr. Greg Bailey, MD.
